Key Findings:  This review discusses how synthetic derivatives of THCV interact with CB1 and CB2 receptors and suggests it acts as a neutral antagonist and partial agonist.
Type of Study:  Meta-analysis
Study Result:  Inconclusive
Research Location(s):  Italy, United Kingdom
Year of Pub:  2020
Cannabinoids Studied:  Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source:  Not Applicable
Citation:  Tinto F, et al. Synthesis of the Major Mammalian Metabolites of THCV. J Nat Prod. 2020; 83:2060-2065. doi: 10.1021/acs.jnatprod.9b00831
Authors:  Tinto F, Villano R, Kostrzewa M, Ligresti A, Straker H, Manzo E